Sanbox:Kamal: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) |
||
(2 intermediate revisions by one other user not shown) | |||
Line 22: | Line 22: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mass | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mass | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | ||
Line 41: | Line 38: | ||
* [[Skin rash]] | * [[Skin rash]] | ||
* [[Chest pain]] | * [[Chest pain]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 62: | Line 56: | ||
* In most patients the mediastinal mass is anterior; associated with pleural effusions. Can produce such complications as superior vena cava syndrome, tracheal obstruction, and pericardial effusions | * In most patients the mediastinal mass is anterior; associated with pleural effusions. Can produce such complications as superior vena cava syndrome, tracheal obstruction, and pericardial effusions | ||
|- | |- | ||
! colspan="2" |T-cell granular lymphocytic<ref name="Rose2004">{{cite journal|last1=Rose|first1=M. G.|title=T-Cell Large Granular Lymphocyte Leukemia and Related Disorders|journal=The Oncologist|volume=9|issue=3|year=2004|pages=247–258|issn=1083-7159|doi=10.1634/theoncologist.9-3-247}}</ref> | ! colspan="2" |T-cell granular lymphocytic<ref name="Rose2004">{{cite journal|last1=Rose|first1=M. G.|title=T-Cell Large Granular Lymphocyte Leukemia and Related Disorders|journal=The Oncologist|volume=9|issue=3|year=2004|pages=247–258|issn=1083-7159|doi=10.1634/theoncologist.9-3-247}}</ref><ref name="pmid22800517">{{cite journal| author=Liu EB, Chen HS, Zhang PH, Li ZQ, Sun Q, Yang QY et al.| title=[Hematopathologic features of T-cell large granular lymphocytic leukemia]. | journal=Zhonghua Bing Li Xue Za Zhi | year= 2012 | volume= 41 | issue= 4 | pages= 229-33 | pmid=22800517 | doi=10.3760/cma.j.issn.0529-5807.2012.04.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22800517 }}</ref><ref name="pmid15958859">{{cite journal| author=Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A| title=Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. | journal=Am J Surg Pathol | year= 2005 | volume= 29 | issue= 7 | pages= 935-41 | pmid=15958859 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15958859 }}</ref> | ||
! | ! | ||
* clonal proliferation of CD8 T cells | * clonal proliferation of CD8 T cells | ||
Line 74: | Line 68: | ||
* Frequent infections | * Frequent infections | ||
* Night sweats | * Night sweats | ||
! | ! | ||
! | ! | ||
Line 94: | Line 85: | ||
! | ! | ||
|- | |- | ||
! colspan="2" |T-cell prolymphocytic leukemia | ! colspan="2" |T-cell prolymphocytic leukemia<ref name="pmid23382603">{{cite journal| author=Graham RL, Cooper B, Krause JR| title=T-cell prolymphocytic leukemia. | journal=Proc (Bayl Univ Med Cent) | year= 2013 | volume= 26 | issue= 1 | pages= 19-21 | pmid=23382603 | doi= | pmc=3523759 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23382603 }}</ref> | ||
! | ! | ||
* Abnormal proliferation of mature T cells (post thymic) | |||
! | ! | ||
* [[Fever]] | |||
* [[Fatigue]] | |||
* [[Weight loss]] | |||
* [[Night sweats]] | |||
* [[Skin rash]] | |||
* Hepatomegaly | |||
* Splenomegaly | |||
* Lymphadenopathy | |||
! | ! | ||
! | ! | ||
Line 106: | Line 103: | ||
! | ! | ||
! | ! | ||
* CD2 | |||
* CD3 | |||
* CD4 | |||
* CD5 | |||
* CD7 | |||
* CD56 | |||
* TCL1 | |||
! | ! | ||
** lymphocytes with abundant basophilic, nongranular cytoplasm, atypical nucleus | |||
** cytoplasmic protrusions (blebs) | |||
! | ! | ||
! | ! | ||
Line 124: | Line 130: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 153: | Line 153: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 185: | Line 182: | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Cutaneous manifestations | * Cutaneous manifestations | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |Beta F1+, [[CD2]]-/+, [[CD3]]+, [[CD3]]- ([[CD4]]-positive variant), [[CD4]]+ ([[CD4]]-positive variant), [[CD4]]-, [[CD5]]-, [[CD7]]+/-, [[CD8]]+, [[CD8]]- ([[CD4]]-positive variant), [[Granzyme B|Granzyme B+]], and [[perforin]]+ | | align="center" style="background:#F5F5F5;" + |Beta F1+, [[CD2]]-/+, [[CD3]]+, [[CD3]]- ([[CD4]]-positive variant), [[CD4]]+ ([[CD4]]-positive variant), [[CD4]]-, [[CD5]]-, [[CD7]]+/-, [[CD8]]+, [[CD8]]- ([[CD4]]-positive variant), [[Granzyme B|Granzyme B+]], and [[perforin]]+ | ||
Line 214: | Line 208: | ||
** [[Myalgias]] | ** [[Myalgias]] | ||
** Painless swellings on extremities and trunk | ** Painless swellings on extremities and trunk | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 254: | Line 245: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 282: | Line 270: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 314: | Line 299: | ||
** [[Bone pain]] | ** [[Bone pain]] | ||
** Painless swelling in the neck, axilla, groin, thorax, and abdomen | ** Painless swelling in the neck, axilla, groin, thorax, and abdomen | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 335: | Line 317: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[fever]], [[weight loss]], skin rash, [[night sweats]], [[edema]], chest pain, [[abdominal pain]], [[bone pain]], [[fatigue]], [[dark urine]], [[shortness of breath]], [[chronic pain]], swelling of joints and painless swelling in the neck, axilla, groin, thorax, and abdomen | * [[fever]], [[weight loss]], skin rash, [[night sweats]], [[edema]], chest pain, [[abdominal pain]], [[bone pain]], [[fatigue]], [[dark urine]], [[shortness of breath]], [[chronic pain]], swelling of joints and painless swelling in the neck, axilla, groin, thorax, and abdomen | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 363: | Line 342: | ||
** Enlarged liver and/or spleen | ** Enlarged liver and/or spleen | ||
** Frequent infections | ** Frequent infections | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | |
Latest revision as of 20:00, 23 January 2019
==References==
Differentiating NHL
Category | Disease | Etiology | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | Immunochemistry | Histopathology | Gold standard | Associated findings | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T cell lymphoma | Precursor T-cell lymphoblastic leukemia/lymphoma[1][2] |
|
|
|
| ||||||||
T-cell granular lymphocytic[3][4][5] |
|
|
|
Medium / large lymphocytes with abundant cytoplasm having azurophilic granules | |||||||||
T-cell prolymphocytic leukemia[6] |
|
|
|
|
|||||||||
Adult T cell leukemia/lymphoma[7][8][9] |
|
|
+ | Hypercalcemia | |||||||||
Anaplastic large cell lymphoma[10][11][12][13] |
|
|
+ | + |
|
Painless swelling in the neck, axilla, groin, thorax, and abdomen | |||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome[14][15][16] |
|
|
+ | + |
|
Beta F1+, CD2-/+, CD3+, CD3- (CD4-positive variant), CD4+ (CD4-positive variant), CD4-, CD5-, CD7+/-, CD8+, CD8- (CD4-positive variant), Granzyme B+, and perforin+ |
|
| ||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma[17][18][19] |
|
|
|
|||||||||
Hepatosplenic T-cell lymphoma[20][21][22] |
|
|
+ | + |
|
|
|||||||
Enteropathy-type intestinal T-cell lymphoma[23][24][25] |
|
|
+ | + | CD3+, CD4-, CD5-, CD7+, CD30+, CD56+, CD103+, CD8+/-, and TCR beta+/- |
|
|||||||
Extranodal T-cell lymphoma, nasal type[26][27][28] |
|
|
|
||||||||||
Angioimmunoblastic T-cell lymphoma[29][30][31] |
|
|
|
||||||||||
Peripheral T-cell lymphoma, unspecified[32][33] |
|
|
|
|
- ↑ Shelly D, Gujral S (2017). "Early T-Cell Precursor Acute Lymphoblastic Leukaemia/Lymphoma: Immunohistochemical Evaluation of Four Lymph Node Biopsies". J Clin Diagn Res. 11 (7): EL01–EL02. doi:10.7860/JCDR/2017/29352.10164. PMC 5583929. PMID 28892922.
- ↑ You MJ, Medeiros LJ, Hsi ED (2015). "T-lymphoblastic leukemia/lymphoma". Am J Clin Pathol. 144 (3): 411–22. doi:10.1309/AJCPMF03LVSBLHPJ. PMID 26276771.
- ↑ Rose, M. G. (2004). "T-Cell Large Granular Lymphocyte Leukemia and Related Disorders". The Oncologist. 9 (3): 247–258. doi:10.1634/theoncologist.9-3-247. ISSN 1083-7159.
- ↑ Liu EB, Chen HS, Zhang PH, Li ZQ, Sun Q, Yang QY; et al. (2012). "[Hematopathologic features of T-cell large granular lymphocytic leukemia]". Zhonghua Bing Li Xue Za Zhi. 41 (4): 229–33. doi:10.3760/cma.j.issn.0529-5807.2012.04.004. PMID 22800517.
- ↑ Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A (2005). "Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review". Am J Surg Pathol. 29 (7): 935–41. PMID 15958859.
- ↑ Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
- ↑ Matutes E (2007). "Adult T-cell leukaemia/lymphoma". J. Clin. Pathol. 60 (12): 1373–7. doi:10.1136/jcp.2007.052456. PMC 2095573. PMID 18042693.
- ↑ Matutes E (2007) Adult T-cell leukaemia/lymphoma. J Clin Pathol 60 (12):1373-7. DOI:10.1136/jcp.2007.052456 PMID: 18042693
- ↑ Shimoyama M (1991). "Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)". Br J Haematol. 79 (3): 428–37. PMID 1751370.
- ↑ Al-Ahmad, Selma; Maertens, Vincent; Libeer, Christophe; Schelfhout, Vera; Vanhoenacker, Filip; Boeckx, Nancy; Vandevenne, Marleen (2017). "The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature". Acta Clinica Belgica. 72 (6): 454–460. doi:10.1080/17843286.2017.1312057. ISSN 1784-3286.
- ↑ Yu L, Yan LL, Yang SJ (2014). "Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature". Int J Clin Exp Pathol. 7 (8): 4806–16. PMC 4152041. PMID 25197351.
- ↑ de Campos FPF, Zerbini MCN, Felipe-Silva A, Simões AB, Lovisolo SM, da Fonseca LG; et al. (2014). "Unusual clinical presentation of anaplastic large cell lymphoma". Autops Case Rep. 4 (1): 21–27. doi:10.4322/acr.2014.004. PMC 5470561. PMID 28652989.
- ↑ Watanabe M, Ogawa Y, Itoh K; et al. (January 2008). "Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma". Lab. Invest. 88 (1): 48–57. doi:10.1038/labinvest.3700696. PMID 17965727.
- ↑ Foss, Francine M.; Girardi, Michael (2017). "Mycosis Fungoides and Sezary Syndrome". Hematology/Oncology Clinics of North America. 31 (2): 297–315. doi:10.1016/j.hoc.2016.11.008. ISSN 0889-8588.
- ↑ Campbell, J. J.; Clark, R. A.; Watanabe, R.; Kupper, T. S. (2010). "Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors". Blood. 116 (5): 767–771. doi:10.1182/blood-2009-11-251926. ISSN 0006-4971.
- ↑ Vonderheid, Eric C.; Bernengo, Maria Grazia; Burg, Günter; Duvic, Madeleine; Heald, Peter; Laroche, Liliane; Olsen, Elise; Pittelkow, Mark; Russell-Jones, Robin; Takigawa, Masahiro; Willemze, Rein (2002). "Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas". Journal of the American Academy of Dermatology. 46 (1): 95–106. doi:10.1067/mjd.2002.118538. ISSN 0190-9622.
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016
- ↑ Subcutaneous panniculitis-like T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52df/. Accessed on March 08, 2016
- ↑ Parveen Z, Thompson K (2009). "Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas". Arch Pathol Lab Med. 133 (2): 303–8. doi:10.1043/1543-2165-133.2.303. PMID 19195975.
- ↑ van de Meeberg MM, Derikx LA, Sinnige HA, Nooijen P, Schipper DL, Nissen LH (2016). "Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy". World J Gastroenterol. 22 (47): 10465–10470. doi:10.3748/wjg.v22.i47.10465. PMC 5175260. PMID 28058028.
- ↑ Shi, Yang; Wang, Endi (2015). "Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer–Cell Neoplasms". Archives of Pathology & Laboratory Medicine. 139 (9): 1173–1180. doi:10.5858/arpa.2014-0079-RS. ISSN 0003-9985.
- ↑ Alsohaibani FI, Abdulla MA, Fagih MM (2011). "Hepatosplenic T-cell lymphoma". Indian J Hematol Blood Transfus. 27 (1): 39–42. doi:10.1007/s12288-010-0051-1. PMC 3102508. PMID 22379294.
- ↑ Delabie, J.; Holte, H.; Vose, J. M.; Ullrich, F.; Jaffe, E. S.; Savage, K. J.; Connors, J. M.; Rimsza, L.; Harris, N. L.; Muller-Hermelink, K.; Rudiger, T.; Coiffier, B.; Gascoyne, R. D.; Berger, F.; Tobinai, K.; Au, W. Y.; Liang, R.; Montserrat, E.; Hochberg, E. P.; Pileri, S.; Federico, M.; Nathwani, B.; Armitage, J. O.; Weisenburger, D. D. (2011). "Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project". Blood. 118 (1): 148–155. doi:10.1182/blood-2011-02-335216. ISSN 0006-4971.
- ↑ Bautista-Quach MA, Ake CD, Chen M, Wang J (September 2012). "Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features". J Gastrointest Oncol. 3 (3): 209–25. doi:10.3978/j.issn.2078-6891.2012.024. PMC 3418529. PMID 22943012.
- ↑ Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 26, 2016
- ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016
- ↑ Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016
- ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 18, 2016
- ↑ Swerdlow, S.H.; Campo, E.; Harris, N.L.; Jaffe, E.S.; Pileri, S.A.; Stein, H.; Thiele, J.; Vardiman, J.W (2008). "11 Mature T- and NK-cell neoplasms: Angioimmunoblastic T-cell lymphoma". WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC WHO Classification of Tumours. 2 (4th ed.). IARC. ISBN 9283224310.
- ↑ [1] Quintanilla-Martinez L, Fend F, Moguel LR, Spilove L, Beaty MW, Kingma DW, Raffeld M, Jaffe ES. "Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection." Am J Surg Pathol. 1999 Oct;23(10):1233-40. PMID: 10524524
- ↑ Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015
- ↑ Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P (August 2012). "Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters". Blood. 120 (7): 1466–9. doi:10.1182/blood-2012-02-408542. PMID 22760778.
- ↑ Jha, KunalKishor; Gupta, SureshK; Saluja, Harpreet; Subedi, Nuwadatta (2017). "Peripheral T-cell lymphoma, not otherwise specified". Journal of Family Medicine and Primary Care. 6 (2): 427. doi:10.4103/jfmpc.jfmpc_323_16. ISSN 2249-4863.